VOLUME 1: INTEGRATING MODERN HEALTH TECHNOLOGIES AND TRADITIONAL THERAPIES TO PROMOTE GOOD HEALTH SECTION 1: BIOTECHNOLOGICAL INNOVATIONS FOR SUSTAINABLE DEVELOPMENT TOWARDS GOOD HEALTH CARE SYSTEM 1. ADVANCED TECHNOLOGIES FOR DISEASE INTERVENTION: INNOVATIONS ACROSS PRECISION MEDICINE 2. EMERGING APTAMER DIAGNOSTICS: NEXT GEN POINT-OF-CARE (POC) TECHNOLOGY 3. ROLE OF APTAMERS IN MOLECULAR MEDICINE 4. CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) AND BEYOND: REVOLUTIONIZING PRECISION MEDICINE AND GENETIC THERAPIES 5. BIOSIMILARS IN CONTEMPORARY MEDICINE: FROM MOLECULAR DESIGN TO GLOBAL CLINICAL TRANSLATION 6. SWEET SITE OF RNA : DISCOVERY AND IMPLICATION OF GLYCO RNA IN HEALTH AND DISEASE 7. THE ROLE OF ER STRESS IN DISEASE AND IN THERAPEUTIC INTERACTION SECTION 2: POTENTIAL OF STEM CELLS AND REGENERATIVE MEDICINE 8.
ADULT STEM CELLS AND APPLICATIONS 9. EMBRYONIC STEM CELL RESEARCH: SCIENTIFIC ADVANCES AND BIOETHICAL CHALLENGES 10. ORGANOIDS AND LAB-GROWN TISSUES: A NEW FRONTIER IN DISEASE MODELING AND REGENERATIVE MEDICINE 11. 3D BIOPRINTING AND TISSUE ENGINEERING: BUILDING THE FUTURE OF TRANSPLANTATION 12. ADVANCEMENTS IN HUMAN-BASED BIOMATERIALS FOR 3D BIOPRINTING TECHNOLOGIES 13. POTENTIAL ROLE OF 3D-BIOPRINTING OF RECAPITULATED ORGANS AND TISSUES IN MODERN MEDICINE: AN OVERVIEW OF CARDIOVASCULAR DISEASES, CANCER, AND NON-CANCER APPLICATIONS SECTION 3: ARTIFICIAL INTELLIGENCE & MACHINE LEARNING IN HEALTHCARE 14. ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN MICROBIAL DECIPHERING 15. ARTIFICIAL INTELLIGENCE IN CLINICAL DIAGNOSTICS AND DECISION MAKING 16.
MODELING AND PREDICTING TO UNDERSTAND INFECTIOUS DISEASE TRANSMISSION 17. THE FUTURE OF HEALING: AI-DRIVEN PRECISION MEDICINE FOR PERSONALIZED HEALTH CARE 18. MOLECULAR EPIDEMIOLOGICAL APPROACH IN DISEASE MANAGEMENT SECTION 4: MOLECULAR INSIGHTS AND ADVANCED THERAPEUTICS IN DISEASE MANAGEMENT 19. MAPPING MECHANISMS OF METASTASIS AND METABOLISM: ADVANCES IN UNDERSTANDING THE COMPLEXITY OF THETUMOR MICROENVIRONMENT 20. MOLECULAR PATHOPHYSIOLOGY OF STROKE: MECHANISTIC INSIGHTS, BIOMARKERS, AND EMERGING THERAPEUTIC TARGETS 21. PHARMACOTHERAPY OF HEART FAILURE: CURRENT TRENDS AND FUTURE DIRECTIONS 22. MOLECULAR INTERVENTIONS IN HEART FAILURE: GENE EDITING AND GENE THERAPY 23. ARRHYTHMIA-INDUCED SUDDEN CARDIAC DEATH: INSIGHTS AND PROSPECTS ON PATHOPHYSIOLOGY, BIOMARKERS, AND THERAPEUTIC STRATEGIES 24.
ADVANCED STRATEGIES FOR DETECTION AND TREATMENT OF HIGH-RISK ATHEROSCLEROTIC PLAQUES: THE ROLE OF SINGLE-CELL RNA SEQUENCING SECTION 5: NANOTECHNOLOGY AND BIOMATERIALS IN MODERN MEDICINE 25. PIONEERING ALZHEIMER''S DISEASE THERAPIES: INSIGHTS INTO PRECISION MEDICINE, NANOTHERAPEUTICS, AND STEM CELL INNOVATIONS 26. EVOLVING PARADIGMS IN ALZHEIMER''S DISEASE: FROM PATHOGENESIS TO PRECISION THERAPIES SECTION 6: MICROBIOME, MENTAL HEALTH, AND INTEGRATIVE DISEASE MANAGEMENT 27. MICROBIOME MEDICINE: THE GUT-IMMUNE-BRAIN AXIS IN HEALTH AND DISEASE 28. THE CRUCIAL ROLES OF GUT MICROBIOTA IN THE DEVELOPMENT OF NON-COMMUNICABLE DISEASES WITH SPECIAL FOCUS ON THE EFFICACY OF PROBIOTICS AND BOVINE COLOSTRUM IN THE MANAGEMENT OF GASTROINTESTINAL DISORDERS IN ADULTS AND CHILDREN 29. THE PATHOPHYSIOLOGICAL RELATIONSHIP BETWEEN DIABETES MELLITUS AND ALZHEIMER''S DISEASE AND MANAGEMENT WITH HERBAL REMEDIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL STUDIES. 30. EPIGENOME, NUTRIGENOME: IMPLICATIONS IN EVOLUTION OF TYPE 2 DIABETES 31.
INSIGHTS INTO THE COMPLEXITIES OF DEMENTIA: DIAGNOSIS, THERAPEUTICS AND CURRENT RESEARCH 32. COGNITIVE DECLINE AND DEMENTIA IN ELDERLY HUMANS: HOLISTIC APPROACHES FOR THE PREVENTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES AND PSYCHIATRIC DISORDERS 33. REVOLUTIONIZING DENTAL CARE: A NEW ERA OF PRECISION, PERSONALIZATION, AND INNOVATION 34. OSTEOPOROSIS AS A PUBLIC HEALTH PROBLEM 35. INTEGRATIVE MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH YOGIC INTERVENTIONS 36. CHALLENGES IN THE EARLY DIAGNOSIS OF RESPIRATORY DISEASES AND POSSIBLE INTERVENTIONS 37. PRECISION MEDICINE IN ACUTE AND CHRONIC PANCREATITIS 38. KIDNEY DISEASE - INNOVATIONS AND SOLUTIONS 39.
PATHOPHYSIOLOGY OF CHRONIC KIDNEY DISEASE: EPIDEMIOLOGY, DIAGNOSTICBIOMARKERS, AND MANAGEMENT WITH PROBIOTICS AND PREBIOTICS 40. CURRENT TRENDS AND CHALLENGES IN REPRODUCTIVE HEALTH ACROSS GENDERS 41. MALE BREAST CANCER: RARELY KNOWN DISEASE RANBIR C. SOBTI SR. AND JAGMOHAN SINGH VOLUME 2: STRATEGIES FOR COMBATING DISEASES THROUGH NEW THERAPEUTICS, DRUG DEVELOPMENT, NUTRITIONAL APPROACHES, NUTRITION, AND HOLISTIC THERAPIES SECTION 1: INNOVATIONS IN DRUG DISCOVERY, DELIVERY SYSTEMS, AND REPURPOSING 42. CARRAGEENAN AND FUCOIDAN-BASED DELIVERY SYSTEMS FOR ORAL DELIVERY OF POLYPHENOLS: A REVIEW 43. RECENT DEVELOPMENTS AND EMERGING TRENDS IN DRUG DISCOVERY 44. EXPLORING NEW APPLICATIONS OF EXISTING DRUGS IN CANCER THERAPY 45.
INNOVATIONS IN NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY IN CANCER PATIENTS 46. NANOTECHNOLOGY-STEERED APPROACHES IN THE FIELD OF PHYTOPHARMACEUTICALS: ENHANCED BIOAVAILABILITY, THERAPEUTIC VALUE AND SITE-SPECIFIC TARGETING 47. NANOMATERIALS: TYPES, CHARACTERIZATION METHODS, MECHANISMS AS ANTIMICROBIALS- A REVIEW 48. NANOMATERIAL AS ANTI-MALARIAL DRUG CARRIERS FOR THE EFFECTIVE TREATMENT OF MALARIA 49. COMPOSITE LRP AND VGG NETWORKS FOR BRAIN TUMOR ANALYSIS 50. VOL 2, CH 9: COMPARATIVE ANALYSIS OF CNN AND TRANSFORMER ARCHITECTURES FOR MELANOMA DETECTION USING DERMOSCOPIC IMAGES 51. VOL 2, CH 10: BIONANOCOMPOSITES IN ANTI-INFLAMMATORY ACTIVITY 52. VOL 2, CH 11: SCANDIUM-LABELED PET RADIOPHARMACEUTICALS IN RADIOTHERANOSTICS: PRECLINICAL INSIGHTS AND CLINICAL PERSPECTIVES SECTION 2: ADVANCES IN VACCINES AND IMMUNOTHERAPIES 53.
EMERGING VACCINE TECHNOLOGIES: REVOLUTIONIZING THE PREVENTION OF PANDEMICS 54. MRNA VACCINE TECHNOLOGY: THE NEW ERA OF INFECTIOUS DISEASE CONTROL AND CANCER IMMUNOTHERAPY 55. VACCINE-BASED THERAPEUTIC INTERVENTIONS IN UVEAL MELANOMA MANAGEMENT: A CONCEPTUAL REVIEW 56. EDIBLE VACCINES AND HUMAN HEALTH: REALITY AND PREDICTIONS 57. TYPHOID VACCINES: THE ROADWAY TO EFFECTIVE CONTROL 58. REWIRING THE IMMUNE SYSTEM: ROLE OF CAR-T CELLS IN CANCER TREATMENT 59. TUNING YAYS-NAYS FOR CHIMERIC ANTIGEN RECEPTOR BASED CANCER IMMUNOTHERAPY EFFICACY SECTION 3 : FUNCTIONAL FOODS, NUTRITION, AND CHRONIC DISEASE MANAGEMENT 60. PALUDICULTURE: A SOURCE OF POLYPHENOLS FOR CLINICAL NUTRITION AND FAVOURABLE CARBON FOOTPRINT 61.
SECONDARY METABOLITES LIKE FLAVONOIDS USED FOR CANCER TREATMENT: RECENT TRENDS AND FUTURE PERSPECTIVES 62. DEVELOPMENT OF PHYTOCHEMICAL-BASED FOOD PRODUCTS FOR THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES 63. THE FUTURE OF PROTEIN SECURITY: AN OVERVIEW OF POTENTIAL ALTERNATIVES TO NON-ANIMAL PROTEIN SOURCES 64. THE FARM-TO-FORK STRATEGY: FROM PRODUCTION AND MANUFACTURING TO SUSTAINABLE HEALTHYFOOD SUPPLY 65. THE FUTURE OF FOODS: ALTERNATIVE PROTEIN SOURCES 66. NUTRITIONAL AND THERAPEUTIC BENEFITS OF MILLETS IN HEALTH AND DISEASE: A SYSTEMATIC REVIEW FOR PREVENTING NON-COMMUNICABLE DISEASES 67. THE ROLE OF FUNCTIONAL FOODS, PLANT PROTEINS, AND OILSEEDS IN NUTRITIONAL STRATEGIES FOR DISEASE PREVENTION: AN OVERVIEW 68. PROBIOTICS FROM TRADITIONAL AND CLINICAL PROSPECTIVES 69.
THE ROLE OF PROBIOTICS IN CANCER PREVENTION AND TREATMENT SECTION 4 : MARINE AND MICROBIAL RESOURCES FOR HEALTH AND WELL-BEING 70. HARVESTING THE BOUNTY OF THE SEAS FOR SUSTAINABLE FOOD SUPPLY, DIETARY SUPPLEMENTS, NUTRACEUTICALS, AND MEDICINAL INGREDIENTS 71. GLOBALLY SUSTAINABLE PRODUCTS OF SEA ORIGIN FOR HEALTH PROMOTION AND DISEASE PREVENTION: AN OVERVIEW ON THE DISCOVERY OF MARINE-DERIVED FOODS AND NUTRACEUTICALS SECTION 5 : HERBAL MEDICINE, NATURAL COMPOUNDS, AND INTEGRATIVE THERAPIES 72. HERBAL INTERVENTIONS FOR THE TREATMENT OF ALCOHOL ADDICTION 73. NATURAL PRODUCTS-BASED NIOSOMAL ANTI-CANCER FORMULATIONS: RECENT TRENDS AND FUTURE PERSPECTIVES 74. BIOLOGICAL ACTIVITIES OF ERIGERON ANNUS AND NERIUM INDICUM 75. BIOLOGICAL ACTIVITIES OF RUMEX NEPALENSIS AND HEDYCHIUM SPICATUM ERIGERON ANNUS AND NERIUM INDICUM 76. AN OVERVIEW OF THE PAST, PRESENT, AND FUTURE OF NATURAL ANTICANCER MEDICINES DERIVED FROM PLANTS AND MARINE SOURCES: EFFICACY, SAFETY, AND MECHANISMS.